Dr. Adam Abdullahi, a Nigerian infectious disease scientist and public health specialist working at the intersection of epidemic preparedness, infectious disease research, and global health policy, has been selected to participate in the 75th Lindau Nobel Laureate Meeting.
Known as one of the world’s most prestigious scientific gatherings the meeting brings together Nobel Laureates and outstanding early-career researchers from across the globe.
Slated to hold from 28th June to 3rd July 2026 in Lindau, Germany, the meeting will convene approximately 70 Nobel Laureates and more than 600 Young Scientists representing over 100 countries for a week of scientific dialogue, interdisciplinary exchange, and collaboration.
Participants are selected through a highly competitive international process that recognizes scientific excellence, leadership potential, and a demonstrated commitment to addressing global challenges.
Dr. Abdullahi’s selection reflects his growing contributions at the interface of infectious disease science, pandemic preparedness, and health systems strengthening, particularly across Africa.
His research spans laboratory science, epidemiology, implementation research, and health policy, with a focus on generating evidence that strengthens epidemic preparedness, informs treatment strategies, and supports resilient health systems in resource-constrained settings. His work has contributed to advances in understanding HIV drug resistance, SARS-CoV-2 immune responses, Mpox, and other emerging infectious disease threats.
The Nigerian Public Health Scientist is affiliated with the Institute of Human Virology Nigeria (IHVN), the University of Cambridge, and the Harvard T.H. Chan School of Public Health. His work increasingly focuses on strengthening epidemic intelligence, disease surveillance, pandemic preparedness, and equitable access to diagnostics, vaccines, and therapeutics – areas that have become central to the global health agenda.
The 75th Lindau Nobel Laureate Meeting celebrates decades of scientific excellence while fostering dialogue across disciplines to address complex global challenges. This year’s meeting will explore how collaboration between scientists, policymakers, and innovators can accelerate scientific discovery and translate research into solutions with societal impact.
Reflecting on his selection, Dr. Abdullahi said:
“The greatest challenges facing global health today are no longer purely scientific – they are also challenges of implementation, governance, and collaboration. Meetings such as Lindau provide a unique opportunity to learn from Nobel Laureates while building the international partnerships needed to translate scientific discovery into stronger systems that can detect, respond to, and prevent future epidemics”.
Dr. Abdullahi’s participation underscores the growing contribution of African scientists to international scientific leadership and highlights the continent’s increasing role in shaping research, innovation, and policy on pandemic preparedness and global health security. As one of the young scientists selected to attend this landmark anniversary meeting, he will join a global network committed to advancing science in service of society.
He joins other outstanding young scientists selected and sponsored by the B. Braun Foundation (B. Braun-Stiftung), Germany to participate in the high-level meeting.
